Microbial Technologies Enhanced by Artificial Intelligence for Healthcare Applications

被引：1

作者：

Yu, Taeho ^{[1
,2
]}

Chae, Minjee ^{[1
,2
,3
]}

Wang, Ziling ^{[1
,2
]}

Ryu, Gahyeon ^{[1
,2
]}

Kim, Gi Bae ^{[1
,2
,4
]}

Lee, Sang Yup ^{[1
,2
,3
,4
,5
]}

机构：

[1] Korea Adv Inst Sci & Technol KAIST, KAIST Inst BioCentury, Dept Chem & Biomol Engn BK21 Four, Metab & Biomol Engn Natl Res Lab, Daejeon, South Korea

[2] Korea Adv Inst Sci & Technol, Generat Collaborat Lab, Syst Metab Engn & Syst Healthcare Cross, Daejeon, South Korea

[3] Korea Adv Inst Sci & Technol, Grad Sch Engn Biol, Daejeon, South Korea

[4] Korea Adv Inst Sci & Technol, BioProc Engn Res Ctr, Daejeon, South Korea

[5] Korea Adv Inst Sci & Technol, Ctr Synthet Biol, Daejeon, South Korea

来源：

MICROBIAL BIOTECHNOLOGY | 2025年 / 18卷 / 03期

基金：

新加坡国家研究基金会;

关键词：

artificial intelligence; drug; healthcare; microbial technology; DRUG; DESIGN;

D O I：

10.1111/1751-7915.70131

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The combination of artificial intelligence (AI) with microbial technology marks the start of a major transformation, improving applications throughout biotechnology, especially in healthcare. With the capability of AI to process vast amounts of biological big data, advanced microbial technology allows for a comprehensive understanding of complex biological systems, advancing disease diagnosis, treatment and the development of microbial therapeutics. This mini review explores the impact of AI-integrated microbial technologies in healthcare, highlighting advancements in microbial biomarker-based diagnosis, the development of microbial therapeutics and the microbial production of therapeutic compounds. This exploration promises significant improvements in the design and implementation of health-related solutions, steering a new era in biotechnological applications.

引用

页数：9

共 63 条

[1] Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli [J].